InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Wednesday, 01/15/2014 10:42:12 PM

Wednesday, January 15, 2014 10:42:12 PM

Post# of 130503
Great twist in the story...finding a possible a CPT code (aligned to LymPro) .....has added a new dimension here. Can you only imagine when the smart money realizes that we can possibly be ramping up revenues shortly and even be profitable by next year....it could potentially light an immediate fire under the PPS and sent it sharply:

Gerald has many good problems; what does he progress and move forward with this rich pipeleine:

1) LymPro - commercialize or sell the division? $$$$
2) Phenoguard partnership = $$$$ (John C. mentioned that it could be partnered in early 2014)
3) PD Lid compound - start Phase 2b trials within months; immediate boost to market capitalization (bought for peanuts = $100k).
4) Retinonis Pigmentosis Orphan - partner with a Pharma - $$$$
5) Attract high quality financing - Wall street readjusts the current market capitalization upward as many assets can be advanced immediately.
6) Wolframs Diabetes Orphan/Type 2 Diabetes - partner with a Pharma - $$$$
7) TBI - big stuff coming later in Jan. (stake is already in the ground); possible big grants coming there. NFL, Govt. or Banyan Biomarkers
8) Another Orphan data announcement - Ischemic Heart disease or a surprise announcement.

Does it get any better than this folks? Wow!!!